The ECP-IM intervention study.
Reed
P I
PI
Gastrointestinal Unit, Wexham Park Hospital, Slough, Berkshire, UK.
D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use; D004311:Double-Blind Method; D004338:Drug Combinations; D005060:Europe; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D013274:Stomach Neoplasms / Q000382:microbiology* / Q000517:prevention & control*
D004338:Drug Combinations; D010919:Placebos; D017291:Clarithromycin; D009853:Omeprazole; D001205:Ascorbic Acid